Implantable Cardioverter Defibrillators Market Share, Size, Trends, and Forecast by 2031

MARKET OVERVIEW

An implantable cardioverter defibrillator (ICD) is a battery-powered device that is implanted under the skin that monitors the heart rate in patients who have prolonged tachycardia or fibrillation. In individuals with persistent ventricular tachycardia or fibrillation, such devices can help prevent impulsive deaths. Implantable cardioverter defibrillator devices are also known to play an important role in preventing cardiac arrest in patients with a history of cardiac arrest or tachycardia associated with a pulseless ventricle.

MARKET SCOPE

The "Global Implantable Cardioverter Defibrillators Market Analysis to 2031" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of the implantable cardioverter defibrillators market with detailed market segmentation by product, end user, and geography. The report provides key statistics on the market status of the leading implantable cardioverter defibrillators market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

•   Based on product, the global implantable cardioverter defibrillators market is segmented into transvenous implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, and cardiac resynchronization therapy defibrillator (CRT-D). The transvenous implantable cardioverter defibrillators is further segmented into biventricular implantable cardioverter defibrillators, single chambered, and dual chambered.
  
•   Based on end user, the market is bifurcated into hospitals, specialty clinics, ambulatory surgical centers, and others
  

MARKET DYNAMICS

Drivers

•   Increase in adoption of S-ICDs
  
•   Emergence of new technologies
  

Restraints

•   Risk associted with these procedures
  

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The implantable cardioverter defibrillators market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the implantable cardioverter defibrillators market in these regions.

IMPACT OF COVID-19 ON IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS

The report covers key developments in the implantable cardioverter defibrillators market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from implantable cardioverter defibrillators market are anticipated to lucrative growth opportunities in the future with the rising demand for implantable cardioverter defibrillators in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the implantable cardioverter defibrillators market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

•   Medtronic
  
•   Abbott
  
•   Boston Scientific Corporation
  
•   Koninklijke Philips N.V.
  
•   ZOLL Medical Corporation
  
•   Physio-Control Inc
  
•   NIHON KOHDEN CORPORATION
  
•   Pacetronix
  
•   EBR Systems Inc.
  
•   MEDICO S.p.A.
  

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Implantable Cardioverter Defibrillators Report Scope